Osstem Implant

Acquired

Korea's leading total dental solution partner

Osstem Implant was founded in 1997, is headquartered in Seoul, South Korea, lists 5001–10000 employees, and has 1 recorded funding round.

Headquarters
Seoul
Employees
5001–10000
Founded
1997
Business Model
B2B
Last Round
Growth EquityOct 2023
Rounds
1
Acquisition Date
Jan 2023

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Osstem Implant Co., Ltd. is a South Korean dental implant and total dental solutions company founded in January 1997. Originally established as D&D System, it was renamed Osstem Implant in 2006 after pioneering the development and commercialization of dental implants in South Korea. The company offers a comprehensive portfolio spanning dental implants, dental equipment and pharmaceuticals (unit chairs, CT scanners, panoramic imaging devices, bone graft materials), dental IT and software (clinic management, insurance claim processing, digital treatment planning with AI), dental clinic interior design, clinical education (having trained over 100,000 practitioners globally), and a dental professional portal. Listed on the KOSDAQ in 2007, Osstem has grown to operate 30 overseas subsidiaries across 34 countries, employing approximately 6,800 staff globally, and recorded sales of approximately USD 938.5 million in 2025. The company has been the world's number one seller of implants for multiple consecutive years and has acquired dental companies including Implacil in Brazil.

Summary

Osstem Implant is a Biotech company based in Seoul, South Korea, founded in 1997. It lists 5001–10000 employees. Its most recent funding was a Growth Equity round in Oct 2023. Investors include Mubadala Investment Company, MBK Partners and Unison Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Growth EquityGrowth EquityOct 2023

Sign up to see all 2 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Osstem Implant on Indexed.vc
<a href="https://indexed.vc/companies/osstem-implant"><img src="https://indexed.vc/api/badge/company/osstem-implant" alt="Osstem Implant on Indexed.vc" width="260" height="76" /></a>